DoD Lupus Research, Transformative Vision Award
ID: 354477Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354477
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted May 28, 2024 12:00 AM
  4. 4
    Due Aug 6, 2024 12:00 AM
Description

The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Lupus Research, Transformative Vision Award". This grant is in the category of Science and Technology and other Research and Development. The grant does not require cost sharing or matching. The total program funding is $2,000,000, and it is expected that one award will be given. The grant is open to unrestricted applicants. The close date for applications is August 6, 2024. The grant supports applications that aim to fulfill an extraordinary vision for improving the quality of life of persons with lupus. The focus is on interventions at the individual and/or health care system level. The grant requires a plan that will test and achieve the vision through the translation of research ideas. Preliminary data are required, and human subject research and clinical trials are allowed. For more information, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

Point(s) of Contact
help@eBRAP.org
Files
Title
Posted
HT942524LRPTVA_GG.pdf
5/29/2024
Similar Opportunities
DoD Lupus Research, Transformative Vision Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Lupus Research, Transformative Vision Development Award". This grant aims to improve the quality of life for individuals with lupus by implementing interventions at the individual and/or health care system level. The grant offers two award mechanisms, the LRP TVDA and the LRP Transformative Vision Award (TVA), which support pilot studies and applications that fulfill an extraordinary vision for improving the quality of life for individuals with lupus. The grant does not require recipients to be awarded a TVDA in order to submit a TVA application. Suitable preliminary studies for the LRP TVDA may include intervention development, safety studies, or trial design refinement. The grant encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, with a focus on improving women's health outcomes and advancing knowledge in this area. The close date for this grant opportunity is August 6, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
DoD Lupus Research, Impact Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA is offering a grant opportunity titled "DoD Lupus Research, Impact Award". This grant aims to support research projects or ideas focused on scientific and clinical lupus issues. The goal is to address these issues and make a significant impact in lupus research and/or lupus disease. The grant encourages applicants to include a well-formulated, testable hypothesis based on strong scientific rationale, along with preliminary data if available. The total program funding is $5,000,000, and it is expected that 5 awards will be granted. The deadline for applications is August 6, 2024. For more information and to apply, please contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DoD Lupus Research, Idea Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DoD Lupus Research, Idea Award". This grant aims to support innovative and high-risk research that could lead to significant advancements in the understanding and treatment of lupus. The grant is open to unrestricted applicants and does not require cost sharing or matching funds. The DoD Lupus Research, Idea Award is specifically designed to fund studies that have the potential to uncover new avenues for investigation in the field of lupus. It encourages researchers to develop new hypotheses or innovative approaches to enhance the existing knowledge of lupus. The award is not intended to support incremental progress in ongoing research projects. The grant does not require the inclusion of preliminary data, but it encourages research that focuses on health areas and conditions that affect women uniquely or disproportionately. The research should analyze sex as a biological variable and relate the anticipated project findings to improvements in women's health outcomes. The total program funding for this grant is $1,500,000, and it is expected to result in five awards. The closing date for applications is August 6, 2024. For more information and assistance, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. By providing a comprehensive summary of this federal grant opportunity, you are contributing to the advancement of lupus research and potentially making a positive impact on the lives of those affected by this condition.
DoD Tuberous Sclerosis Complex, Clinical Translational Research Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Tuberous Sclerosis Complex, Clinical Translational Research Award". This grant aims to support studies that will advance the diagnosis, prognosis, and treatment of Tuberous Sclerosis Complex (TSC). The funding of $3,400,000 is expected to result in two awards. The grant does not require cost sharing or matching. The eligible applicants are unrestricted. The close date for this opportunity is August 1, 2024. The DoD Tuberous Sclerosis Complex, Clinical Translational Research Award focuses on moving promising preclinical and/or clinical research findings closer to clinical application. The projects supported by this grant may include studies analyzing human anatomical substances and/or data associated with completed clinical trials to understand the mechanism of action or improve diagnosis, prognosis, or treatment of TSC. It also supports studies advancing clinical trial readiness through the development of biomarkers, clinical endpoints, and validation of pharmacokinetics/pharmacodynamics. Additionally, pilot clinical trials aimed at obtaining preliminary data for the development of interventions to improve TSC outcomes are encouraged. The grant also supports new studies that improve clinical care of TSC by analyzing existing real-world clinical practice data to develop or improve guidelines in areas such as epilepsy surgery, tumor resection, reproductive health, perinatal surveillance, and care. Preclinical studies with a clinical component are appropriate for this grant, while strictly animal research projects will not be considered. For more information or assistance, you can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. The archive date for this grant opportunity is August 31, 2024.
DoD Joint Warfighter Medical, Military Medical Research and Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a federal grant opportunity titled "DoD Joint Warfighter Medical, Military Medical Research and Development Award". This procurement contract falls under the category of Science and Technology and other Research and Development. The grant does not require cost sharing or matching. The estimated total program funding for this opportunity is $7,400,000, with an expected number of 3 awards to be granted. The purpose of this grant is to fund the continuation of previously DOD-funded research or development efforts that are relevant to the FY24 JWMRP Focus Areas. The aim is to accelerate and augment the development of medical products and healthcare solutions for active-duty Service Members, their Families, Veterans, and/or the American public. Collaboration with DOD organizations is encouraged, and applications/proposals from small businesses and partnerships with industry are also welcomed. The MMRDA mechanism supports a wide range of research projects, including late-stage preclinical studies, late-stage technology development efforts, technology demonstration, and translational research. Additionally, there is a Clinical Research or Clinical Trial Option available to support clinical research/observational studies, all phases of clinical trials/interventional studies, and correlative studies for the development of promising pharmaceutical or biologic candidates, medical devices, and technologies. Applicants are encouraged to collaborate with DOD organizations when it contributes to the success of the research effort. If any funds are designated for DOD laboratories or activities, they should be identified in the application/proposal through the submission of a "Suggested Intragovernmental/Intramural Budget Form," Attachment 15. Applicants are also required to submit additional relevant application/proposal materials if applying under the Clinical Research or Clinical Trial Option. The close date for this grant opportunity is August 29, 2024, and the archive date is September 28, 2024. For any inquiries or assistance, applicants can contact the CDMRP Help Desk via phone at 301-682-5507 or email at help@eBRAP.org.